UCHECHUKWU IFEJI: Open Payments
NPI 1043736846 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 23 payments from 6 companies in 2025. Trend: 2023 $1,615 · 2024 $1,090 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $310 |
| Indivior Inc. | 7 | $219 |
| Alkermes, Inc. | 3 | $52 |
| ABBVIE INC. | 3 | $48 |
| Orexo US, Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: CAPLYTA, SUBLOCADE, ARISTADA, VRAYLAR, Zubsolv, Qelbree.
Industry payments across MD — which companies pay providers there.
